Closing the gap between Regulatory and Development with Milton Yarberry

The Pragmatic Embedded Podcast · 5 Mar 2024 · 51m

What this episode covers

Milton Yarberry, Director of Medical Programs at Integrated Computer Solutions (ICS), discusses bridging the gap between engineering and regulatory teams in medical device development. He identifies key friction points such as process lag, software stacking, and the cognitive burden on developers, arguing that regulatory processes should be viewed as support rather than compliance burdens. Yarberry advocates for a 'regulatory concierge' model where regulatory staff handle administrative overhead, allowing engineers to focus on building safe and effective products through incremental, value-driven processes.

Mentioned

Companies
Integrated Computer Solutions, ICS, Bluefruit
Tools
Squish
Also
FDA, MDR, IEC 62304, Misra

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 38m

    Meet a Guru: Erica Loring

    Erica Loring, a medical device guru at Greenlight Guru, discusses her background in pharmaceuticals and IVDs, emphasizing the critical distinction between Quality Assurance and Regulatory Affairs. She explains how the 'throw it over the wall' mentality creates documentation gaps and costly remediation, advocating for cross-functional collaboration from concept to market. Loring highlights the importance of investing in people, allowing adequate time for development, and rigorously auditing suppliers to ensure successful product launches.

  • Global Medical Device Podcast · 34m

    Similarities & Differences between In Vitro Diagnostic (IVD) Devices & Medical Devices

    Milton Yarberry, Director of Medical Programs at Integrated Computer Solutions (ICS), joins host John Spear to discuss the regulatory and engineering distinctions between In Vitro Diagnostic (IVD) devices and traditional medical devices. They clarify that while IVDs are a subset of medical devices subject to similar quality systems (21 CFR Part 820, ISO 13485), their risk classification is based on the assay's impact rather than direct patient harm. The conversation highlights how IVD manufacturers often struggle with design controls because their background is in clinical science rather than commercial engineering, leading to a focus on analytical fidelity over user interface. They also address the evolving regulatory landscape, including CLIA Waiver requirements, the status of Lab Developed Tests (LDTs), and the impact of the EU MDR/IVDR and FDA Emergency Use Authorizations (EUA).

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Global Medical Device Podcast · 27m

    Meet a Guru: Ryan Behringer

    Ryan Behringer, a Training and Onboarding Medical Device Guru at Greenlight Guru, discusses his journey from a biomedical engineering student at the University of Cincinnati to a product development engineer at an Omaha startup. He explains how he used the Greenlight Guru platform to manage design controls and risk management, successfully achieving 510(k) clearance for his device. Behringer emphasizes the importance of integrating quality and regulatory knowledge early in the engineering process to avoid checkbox compliance and ensure true product value. He now helps other companies implement these systems to streamline their path to market.

  • Embedded.fm · 1h 04m

    305: Humans Have a Terrible Spec Sheet (Repeat)

    Amanda Wozniak, a principal engineer at Amazon Robotics with a background at Analog Devices, the Wyss Institute at Harvard, and NxStage, discusses her career in biomedical engineering and hardware development. She explains the gap between academic theory and practical engineering, detailing how parasitics and non-ideal component behavior often cause circuit failures that textbooks ignore. Wozniak also shares insights on navigating the FDA regulatory process for medical devices, the challenges of managing complex robotics projects, and the importance of avoiding burnout by recognizing engineering as a team sport rather than a solo endeavor.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by The Pragmatic Embedded Podcast. The episode itself belongs to its publisher.